172 related articles for article (PubMed ID: 11197799)
1. Serum KL-6 as a possible marker for amiodarone-induced pulmonary toxicity.
Nakajima M; Kawahara Y; Yoshida K; Miyashita N; Niki Y; Matsushima T
Intern Med; 2000 Dec; 39(12):1097-100. PubMed ID: 11197799
[TBL] [Abstract][Full Text] [Related]
2. SP-D as a marker of amiodarone-induced pulmonary toxicity.
Umetani K; Abe M; Kawabata K; Iida T; Kohno I; Sawanobori T; Kugiyama K
Intern Med; 2002 Sep; 41(9):709-12. PubMed ID: 12322797
[TBL] [Abstract][Full Text] [Related]
3. KL-6 as a serum marker for amiodarone-induced pulmonary toxicity.
Kohno N; Yokoyama A; Kondo K
Intern Med; 2000 Dec; 39(12):1004-5. PubMed ID: 11197780
[No Abstract] [Full Text] [Related]
4. Diagnostic accuracy of KL-6 as a marker of amiodarone-induced pulmonary toxicity.
Endoh Y; Hanai R; Uto K; Tanaka T; Ohta Y; Kasanuki H; Ohnishi S
Pacing Clin Electrophysiol; 2000 Nov; 23(11 Pt 2):2010-3. PubMed ID: 11139980
[TBL] [Abstract][Full Text] [Related]
5. KL-6 as a potential new marker for amiodarone-induced pulmonary toxicity.
Endoh Y; Hanai R; Uto K; Uno M; Nagashima H; Narimatsu A; Takizawa T; Onishi S; Kasanuki H
Am J Cardiol; 2000 Jul; 86(2):229-31. PubMed ID: 10913491
[No Abstract] [Full Text] [Related]
6. Circulating KL-6 levels in patients with drug induced pneumonitis.
Ohnishi H; Yokoyama A; Yasuhara Y; Watanabe A; Naka T; Hamada H; Abe M; Nishimura K; Higaki J; Ikezoe J; Kohno N
Thorax; 2003 Oct; 58(10):872-5. PubMed ID: 14514942
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic usefulness of KL-6 measurements in patients with pulmonary complications after administration of amiodarone].
Endoh Y; Hanai R; Uto K; Uno M; Nagashima H; Takizawa T; Narimatsu A; Ohnishi S; Kasanuki H
J Cardiol; 2000 Feb; 35(2):121-7. PubMed ID: 10713933
[TBL] [Abstract][Full Text] [Related]
8. Detection of interstitial pneumonitis in patients with rheumatoid arthritis by measuring circulating levels of KL-6, a human MUC1 mucin.
Oyama T; Kohno N; Yokoyama A; Hirasawa Y; Hiwada K; Oyama H; Okuda Y; Takasugi K
Lung; 1997; 175(6):379-85. PubMed ID: 9330247
[TBL] [Abstract][Full Text] [Related]
9. [Multiple pulmonary nodules and amiodarone. KL-6 as a new diagnostic tool].
Bernal Morell E; Hernández Madrid A; Marín Marín I; Rodríguez Pena R; González Gordaliza MC; Moro C
Rev Esp Cardiol; 2005 Apr; 58(4):447-9. PubMed ID: 15847740
[TBL] [Abstract][Full Text] [Related]
10. KL-6 as a novel marker for activities of interstitial pneumonia in connective tissue diseases.
Fukaya S; Oshima H; Kato K; Komatsu Y; Matsumura H; Ishii K; Miyama H; Nagai T; Tanaka I; Mizutani A; Katayama M; Yoshida S; Torikai K
Rheumatol Int; 2000; 19(6):223-5. PubMed ID: 11063292
[TBL] [Abstract][Full Text] [Related]
11. Amiodarone pulmonary toxicity: a patient with three recurrences of pulmonary toxicity and consideration of the probable risk for relapse.
Okayasu K; Takeda Y; Kojima J; Yoshizawa A; Kobayashi N; Sugiyama H; Kudo K
Intern Med; 2006; 45(22):1303-7. PubMed ID: 17170505
[TBL] [Abstract][Full Text] [Related]
12. Serum KL-6, a novel mucin-like glycoprotein, as an indicator of interstitial pneumonitis following lobectomy.
Sakuma T; Takahashi K; Ohya N; Usuda K; Handa M
Surg Today; 1999; 29(2):121-8. PubMed ID: 10030736
[TBL] [Abstract][Full Text] [Related]
13. Serum mucin antigen (CASA) as a marker of amiodarone-induced pulmonary toxicity.
Devine PL; Siebert WJ; Morton SL; Scells B; Quin RJ; Heddle WF; Zimmerman PV; Donohoe PJ
Dis Markers; 1998 Nov; 14(3):169-75. PubMed ID: 10427477
[TBL] [Abstract][Full Text] [Related]
14. Role of KL-6 in evaluating the disease severity of rheumatoid lung disease: comparison with HRCT.
Kinoshita F; Hamano H; Harada H; Kinoshita T; Igishi T; Hagino H; Ogawa T
Respir Med; 2004 Nov; 98(11):1131-7. PubMed ID: 15526815
[TBL] [Abstract][Full Text] [Related]
15. Comparative studies of circulating KL-6, type III procollagen N-terminal peptide and type IV collagen 7S in patients with interstitial pneumonitis and alveolar pneumonia.
Kohno N; Yokoyama A; Hirasawa Y; Kondo K; Fujino S; Abe M; Hiwada K
Respir Med; 1997 Oct; 91(9):558-61. PubMed ID: 9415357
[TBL] [Abstract][Full Text] [Related]
16. Serum KL-6 levels in patients with pulmonary complications after allogeneic bone marrow transplantation.
Ashida T; Higashishiba M; Sumimoto Y; Sano T; Miyazato H; Shimada T; Miyatake J; Kawanishi K; Tatsumi Y; Kanamaru A
Int J Hematol; 2001 Dec; 74(4):464-8. PubMed ID: 11794706
[TBL] [Abstract][Full Text] [Related]
17. KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases.
Nakajima H; Harigai M; Hara M; Hakoda M; Tokuda H; Sakai F; Kamatani N; Kashiwazaki S
J Rheumatol; 2000 May; 27(5):1164-70. PubMed ID: 10813282
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of serum KL-6 levels in patients with pulmonary tuberculosis.
Inoue Y; Nishimura K; Shiode M; Akutsu H; Hamada H; Fujioka S; Fujino S; Yokoyama A; Kohno N; Hiwada K
Tuber Lung Dis; 1995 Jun; 76(3):230-3. PubMed ID: 7548906
[TBL] [Abstract][Full Text] [Related]
19. [Clinical usefulness of KL-6 as a serum marker of idiopathic interstitial pneumonia].
Kohno N
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():186-9. PubMed ID: 9216213
[TBL] [Abstract][Full Text] [Related]
20. KL-6: a serum marker for interstitial pneumonia.
Kobayashi J; Kitamura S
Chest; 1995 Aug; 108(2):311-5. PubMed ID: 7634858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
